No Data
Buy Rating Affirmed for 2seventy Bio on Strong Growth Prospects and Financial Stability
2seventy bio | 10-Q: Quarterly report
2seventy Bio Is Maintained at Buy by Canaccord Genuity
2seventy Bio Is Maintained at Buy by Canaccord Genuity
Express News | Canaccord Genuity Maintains Buy on 2seventy Bio, Lowers Price Target to $11
2seventy Bio Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/09/2024 147.19% Canaccord Genuity $12 → $11 Maintains Buy 04/08/2024 169.66% Citigroup $9 → $12 Maintai
2seventy Bio, Inc. (NASDAQ:TSVT) Q1 2024 Earnings Call Transcript
JESSE JAMES8832 : quite a bit better than expected right?
JESSE JAMES8832 : 13.9m was the prediction
TrytosaveabitOP JESSE JAMES8832: I believe so yes?
TrytosaveabitOP JESSE JAMES8832: That rings a bell!
JESSE JAMES8832 : damn i thought this would do much better... short attack?
View more comments...